doc. MUDr. Andrea Janíková, Ph.D.
Associate professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3514, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 167
2023
-
Genomic aberrations detected in circulating tumor DNA from cerebrospinal fluid and plasma of patients with primary and secondary CNS lymphomas with negative flowcytometry.
Year: 2023, type: Conference abstract
-
Home-based cardio-oncology rehabilitation using a telerehabilitation platform in hematological cancer survivors: a feasibility study
BMC SPORTS SCIENCE MEDICINE AND REHABILITATION, year: 2023, volume: 15, edition: 1, DOI
-
Integrativní diagnostika u pacienta s agresivním lymfomem postihujícím centrální nervový systém: využití komplexního NGS panelu a analýzy cfDNA
Year: 2023, type: Conference abstract
-
Volná cirkulující DNA a její potenciál v diagnostice a léčbě maligních lymfomů
Klinicka Onkologie, year: 2023, volume: 36, edition: 4, DOI
2022
-
Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors
FRONTIERS IN CARDIOVASCULAR MEDICINE, year: 2022, volume: 9, edition: April 2022, DOI
-
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)
Annals of hematology, year: 2022, volume: 101, edition: 4, DOI
-
Comparison of DNA and RNA-based approaches for the genetic characterization and stratification of patients with diffuse large B-cell lymphoma
Year: 2022, type: Conference abstract
-
Consolidation Therapy with Brentuximab Vedotin After Autologous Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Czech Republic.
Year: 2022, type: Conference abstract
-
Cvičební programy pro hematoonkologické pacienty
Year: 2022, type:
-
Integrated NGS testing and cfDNA analysis as an approach for aggregate tumor characterization and monitoring in a patient with aggressive lymphoma invading the central neural system.
Year: 2022, type: Conference abstract